Answers are grounded in this paper and cite their sources.
To investigate the clinicopathological and molecular genetic characteristics of Li‑Fraumeni syndrome (LFS). Two patients from LFS pedigrees were analyzed retrospectively using clinicopathological data and genetic sequencing, along with a literature review. Case 1 was a 32‑year‑old female who carried a TP53 truncating mutation in the germline (c.869del, p.R290Pfs*55). Between the ages of 15 to 32 years, she manifested seven unique tumors: conventional osteosarcoma of the left radius, osteoblastic osteosarcoma of the right tibia, renal epithelioid angiomyolipoma, bilateral breast cancer, lung adenocarcinoma, adrenocortical carcinoma, and a benign angiomyofibroblastoma (AMF) located in the abdominal wall. Among these, six were identified as malignant or borderline lesions consistent with the classic LFS tumor spectrum, whereas the AMF contained the identical germline TP53 mutation and has not been previously described in LFS before. Case 2 was a 2-year-old boy with a germline missense in the TP53 mutation (c.733 G > A, p.G245S). At the age of 2, he was diagnosed with adrenocortical carcinoma with ATRX loss, a condition which was synchronous with his atypical choroid plexus papilloma of the lateral ventricle, a combination hitherto undocumented in relation to LFS. At the age of 9, he experienced a recurrence of adrenocortical carcinoma accompanied by liver metastases. The TP53 variants were validated as pathogenic. The aim of this study was to describe the occurrence of benign AMF (ICD-O: 8826/0) and atypical choroid plexus papilloma (ICD-O: 9390/1) in LFS cases, thereby extending the clinicopathological spectrum of LFS‑associated neoplasms.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: